ONDCP Outlines First Synthetic Drug Control Strategy
In a June 1st press release, the ONDCP announced the White House's first-ever synthetic drug control policy. The strategy outlines the White House's plan with the goal of reducing methamphetamine usage by 15% and domestic meth production by 25% in the next three years. The strategy has a three-pronged approach that consists of "effective implementation of the Combat Meth Act, signed into law by President Bush this March, which sets a national standard for restricting the retail sale of precursor chemicals within the United States; and strengthening law enforcement and border control activities, particularly with Mexico."